skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability

Journal Article · · Bioorganic and Medicinal Chemistry Letters

Sponsoring Organization:
USDOE
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
1358848
Journal Information:
Bioorganic and Medicinal Chemistry Letters, Journal Name: Bioorganic and Medicinal Chemistry Letters Vol. 26 Journal Issue: 2; ISSN 0960-894X
Publisher:
ElsevierCopyright Statement
Country of Publication:
United Kingdom
Language:
English
Citation Metrics:
Cited by: 32 works
Citation information provided by
Web of Science

References (12)

B-Cell Receptor Signaling Inhibitors for Treatment of Autoimmune Inflammatory Diseases and B-Cell Malignancies journal July 2013
A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of GDC-0834 journal April 2015
Mini-Review: Bmx Kinase Inhibitors for Cancer Therapy journal June 2013
Significant Species Difference in Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor journal July 2011
Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk journal March 2009
The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective journal June 2000
Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis journal November 2010
Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834 journal March 2015
Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors journal April 2013
BMX and Its Role in Inflammation, Cardiovascular Disease, and Cancer journal March 2012
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders journal May 2012
The Role of Tec Family Kinases in Myeloid Cells journal January 2004

Similar Records

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834
Journal Article · Sun Mar 01 00:00:00 EST 2015 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1358848

Discovery of BIIB068: A Selective, Potent, Reversible Bruton?s Tyrosine Kinase Inhibitor as an Orall
Journal Article · Wed Jul 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1358848

Discovery of BIIB068: A Selective, Potent, Reversible Bruton?s Tyrosine Kinase Inhibitor as an Orall
Journal Article · Wed Jul 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1358848

Related Subjects